435 related articles for article (PubMed ID: 24348031)
1. Risk assessment of readmissions following an initial COPD-related hospitalization.
Baker CL; Zou KH; Su J
Int J Chron Obstruct Pulmon Dis; 2013; 8():551-9. PubMed ID: 24348031
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with inpatient readmission among managed care enrollees with COPD.
Candrilli SD; Dhamane AD; Meyers JL; Kaila S
Hosp Pract (1995); 2015; 43(4):199-207. PubMed ID: 26357878
[TBL] [Abstract][Full Text] [Related]
3. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Iyer AS; Bhatt SP; Garner JJ; Wells JM; Trevor JL; Patel NM; Kirkpatrick d; Williams JC; Dransfield MT
Ann Am Thorac Soc; 2016 Feb; 13(2):197-203. PubMed ID: 26599286
[TBL] [Abstract][Full Text] [Related]
4. Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease.
Fu AZ; Sun SX; Huang X; Amin AN
Int J Chron Obstruct Pulmon Dis; 2015; 10():909-15. PubMed ID: 25999706
[TBL] [Abstract][Full Text] [Related]
5. Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.
Jiang X; Xiao H; Segal R; Mobley WC; Park H
Clin Ther; 2018 Apr; 40(4):613-626.e1. PubMed ID: 29609879
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis to identify predictors of COPD-related rehospitalization.
Roberts MH; Clerisme-Beaty E; Kozma CM; Paris A; Slaton T; Mapel DW
BMC Pulm Med; 2016 Apr; 16(1):68. PubMed ID: 27130455
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of prediction strategy and care coordination for COPD readmissions.
Bashir B; Schneider D; Naglak MC; Churilla TM; Adelsberger M
Hosp Pract (1995); 2016 Aug; 44(3):123-8. PubMed ID: 27391991
[TBL] [Abstract][Full Text] [Related]
8. Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.
Bollu V; Ernst FR; Karafilidis J; Rajagopalan K; Robinson SB; Braman SS
Int J Chron Obstruct Pulmon Dis; 2013; 8():631-9. PubMed ID: 24353413
[TBL] [Abstract][Full Text] [Related]
9. Readmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients.
Lau CS; Siracuse BL; Chamberlain RS
Int J Chron Obstruct Pulmon Dis; 2017; 12():1891-1902. PubMed ID: 28721034
[TBL] [Abstract][Full Text] [Related]
10. Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.
Slade D; Ray R; Moretz C; Germain G; Laliberté F; Shen Q; Duh MS; MacKnight SD; Hahn B
Pulm Ther; 2021 Jun; 7(1):203-219. PubMed ID: 33728597
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Buhr RG; Jackson NJ; Dubinett SM; Kominski GF; Mangione CM; Ong MK
J Hosp Med; 2020 Apr; 15(4):219-227. PubMed ID: 32118572
[TBL] [Abstract][Full Text] [Related]
12. Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions Database.
Jacobs DM; Noyes K; Zhao J; Gibson W; Murphy TF; Sethi S; Ochs-Balcom HM
Ann Am Thorac Soc; 2018 Jul; 15(7):837-845. PubMed ID: 29611719
[TBL] [Abstract][Full Text] [Related]
13. Using Machine Learning to Predict Likelihood and Cause of Readmission After Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation.
Bonomo M; Hermsen MG; Kaskovich S; Hemmrich MJ; Rojas JC; Carey KA; Venable LR; Churpek MM; Press VG
Int J Chron Obstruct Pulmon Dis; 2022; 17():2701-2709. PubMed ID: 36299799
[TBL] [Abstract][Full Text] [Related]
14. Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary Disease.
Singh U; Wangia-Anderson V; Bernstein JA
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):279-285.e6. PubMed ID: 30053594
[TBL] [Abstract][Full Text] [Related]
15. Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk.
Lin SY; Xue H; Deng Y; Chukmaitov A
Int J Chron Obstruct Pulmon Dis; 2020; 15():143-154. PubMed ID: 32021153
[TBL] [Abstract][Full Text] [Related]
16. Trends in 30-day readmission rates after COPD hospitalization, 2006-2012.
Goto T; Faridi MK; Gibo K; Toh S; Hanania NA; Camargo CA; Hasegawa K
Respir Med; 2017 Sep; 130():92-97. PubMed ID: 29206640
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic obstructive pulmonary disease on readmission after hospitalization for acute heart failure: A nationally representative US cohort study.
Gulea C; Zakeri R; Quint JK
Int J Cardiol; 2019 Sep; 290():113-118. PubMed ID: 31101544
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
[No Abstract] [Full Text] [Related]
19. Risk assessment and rate of readmission within 30 days of discharge after hospitalization for acute exacerbation of chronic obstructive pulmonary disease.
Yılmaz C; Özkan S; Erer OF
Tuberk Toraks; 2021 Sep; 69(3):328-337. PubMed ID: 34581154
[TBL] [Abstract][Full Text] [Related]
20. Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators.
Keshishian A; Xie L; Dembek C; Yuce H
Clin Ther; 2019 Nov; 41(11):2283-2296. PubMed ID: 31630815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
